Skip to content

Psychopharmacology

ISSN 1432-2072, 0033-3158

637 papers in the library · 20,322 citations · publishing 1971-2026

Papers

Sort Most recent Most cited

Plasticity of the acoustic startle reflex in currently abstinent ecstasy (MDMA) users.

Psychopharmacology May 2004 Karsten Heekeren, Jörg Daumann, Mark A. Geyer et al.

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is neurotoxic upon central serotonin systems in experimental animals and probably also in humans. Serotonin is involved in the habituation, sensitization and prepulse inhibition (PPI) of the startle reflex. To study the plasticity of startle reflex in currently abstinent MDMA users. Electromyographic responses to acoustic startle stimuli (pulse...

A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities.

Psychopharmacology May 2004 Fabrizio Schifano

The issue of ecstasy-related fatalities has extensively attracted the attention of both the media and the general public, but less so of the scientific literature. The aim of the present review is to focus on the epidemiological, clinical and pharmacological issues related to ecstasy fatalities. Possibly due to a number of different reasons, the rates of ecstasy-related deaths seem to have...

Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics.

Psychopharmacology May 2004 M Farré, Rafael de la Torre, Brian O Mathúna et al.

3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") is increasingly used by young people for its euphoric and empathic effects. MDMA presents non-linear pharmacokinetics, probably by inhibition of cytochrome P450 isoform 2D6. Users are known to often take more than one dose per session. This practice could have serious implications for the toxicity of MDMA. To evaluate the pharmacological...

Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain.

Psychopharmacology May 2004 Thomas J R Beveridge, Annis O. Mechan, Marie Sprakes et al.

3,4-Methylenedioxymethamphetamine (MDMA) administration to rats produces an acute hyperthermic response and induces localised neuronal activation, which can be visualised via expression of immediate-early genes. The pharmacological and anatomical basis of these effects are unclear. At high doses, MDMA also causes selective neurotoxicity at serotonergic nerve terminals. We investigated the...

Chronic MDMA (ecstasy) use, cognition and mood.

Psychopharmacology May 2004 K McCardle, S Luebbers, J D Carter et al.

It has been suggested that 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) causes damage to the serotonergic system, and that this damage results in cognitive and mood impairments. To examine the effect of chronic MDMA usage on a wide battery of cognitive tests and psychological abilities and processes. In the present study, the performance of 17 participants with a history of MDMA use was...

Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation

Psychopharmacology April 1, 2004 E. Frecska, K. D. White, L. E. Luna 31 citations

RationaleDuring binocular rivalry, two incompatible images are presented to each eye and these monocular stimuli compete for perceptual dominance, with one pattern temporarily suppressed from awareness. One variant of stimulus presentation in binocular rivalry experiments is dichoptic stimulus alternation (DSA), when stimuli are applied to the eyes in rapid reversals. There is preliminary...

DOI: 10.1007/s00213-003-1701-x (opens in new tab) Ayahuasca Binocular rivalry Stimulus psychology Binocular vision +6

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study

Psychopharmacology March 1, 2004 Felix Hasler, Ulrike Grimberg, Marco A. Benz et al. 458 citations

RationaleSerotonin (5-Hydroxytryptamine, 5-HT) receptors play an important role in perception, affect regulation and attention. Pharmacological challenge with the 5-HT(2A) agonist psilocybin (PY) is useful in studying the neurobiological basis of cognition and consciousness.ObjectiveInvestigation of dose-dependent effects of PY on psycho(patho)logical and physiological parameters.MethodsEight...

The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.

Psychopharmacology March 1, 2004 Eduardo R Butelman, Todd J Harris, Mary Jeanne Kreek 102 citations

Salvinorin A is the active component of the hallucinogenic plant Salvia divinorum. The potential mode of action of this hallucinogen was unknown until recently. A recent in vitro study detected high affinity and efficacy of salvinorin A at kappa-opioid receptors. It was postulated that salvinorin A would produce discriminative stimulus effects similar to those of a high efficacy kappa-agonist...

Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys.

Psychopharmacology September 2003 Zuzana Justinova, Gianluigi Tanda, Godfrey H Redhi et al.

Interest in therapeutic activities of cannabinoids has been restrained by the fact that they are most often mediated through activation of cannabinoid CB1 receptors, the same receptors that mediate the effects of delta9-tetrahydrocannabinol (THC) and are responsible for the abuse liability of marijuana. Persistent intravenous self-administration of THC by animals was first demonstrated in...

Affinity and specificity of N-methyl- D-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats.

Psychopharmacology February 1, 2003 Jenny L Wiley, Sarah A Harvey, Robert L Balster et al. 27 citations

Phencyclidine (PCP) binds with high affinity to a site located within the ionophore of N-methyl- D-aspartate (NMDA) receptors. Previous studies have demonstrated that PCP and other high-affinity NMDA channel blockers reliably disrupt prepulse inhibition (PPI) of acoustic startle, an animal model of sensorimotor gating used to study attentional deficits associated with schizophrenia. Recently, a...

DOI: 10.1007/s00213-002-1297-6 (opens in new tab) Full text (opens in new tab) Prepulse inhibition ppi Attentional filter Sensory gating Attention disruption +11

Interaction between naltrexone and oral THC in heavy marijuana smokers.

Psychopharmacology February 2003 Margaret Haney, Adam Bisaga, Richard W Foltin

Studies in non-human animals suggest that opioid antagonists block the reinforcing effects of cannabinoids. The present studies in humans investigated how naltrexone modulates (1) the subjective and physiological effects of oral THC in comparison to methadone, (2) the reinforcing effects of oral THC, and (3) plasma levels of oral THC. In study 1, marijuana smokers (n=9) received naltrexone (0,...

Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice.

Psychopharmacology February 2003 Randy L Smith, Robert J. Barrett, Elaine Sanders‐bush

The drug discrimination procedure has proven to be a valuable tool for studying the mechanism of action of psychoactive drugs. Recently, mice with targeted gene mutations have been developed that may also prove useful in evaluating the role of specific receptors in mediating the actions of drugs. We were interested in studying the effects of hallucinogens in genetically modified mice using the...

Nefazodone decreases anxiety during marijuana withdrawal in humans.

Psychopharmacology January 2003 Margaret Haney, Carl L. Hart, Amie S Ward et al.

Symptoms of marijuana withdrawal include increased irritability, depression and anxiety, and decreased sleep quality. Nefazodone, which is an antidepressant with sedative properties, may attenuate symptoms of marijuana withdrawal. The present within-subject, placebo-controlled study investigated the effects of nefazodone during marijuana withdrawal. Marijuana smokers [ n=7; averaging 6.0...

Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively

Psychopharmacology December 1, 2002 Jordi Riba, Antoni Rodrı́guez-fornells, Manel J. Barbanoj 71 citations

RationaleAyahuasca, a South American psychotropic plant tea, combines the psychedelic agent and 5-HT(2A/2C) agonist N, N-dimethyltryptamine (DMT) with beta-carboline alkaloids showing monoamine oxidase-inhibiting properties. Current human research with psychedelics and entactogens has explored the possibility that drugs displaying agonist activity at the 5-HT(2A/2C) sites temporally disrupt...

Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats.

Psychopharmacology October 2002 Danuta Marona‐lewicka, Deborah Kurrasch‐orbaugh, Jennifer R Selken et al.

There is substantial evidence that lisuride can produce effects linked to 5-HT(1A) receptor occupancy. Nevertheless, this action has generally been ignored in the mechanism of action of lisuride, in favor of an exclusive role for dopamine receptors in considering its antiparkinsonian effects, or an exclusive role of 5-HT(2A/2C) receptor activation in hallucinogenesis. These conclusions are...

Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).

Psychopharmacology July 2002 Jeffrey A Vivian, Courtney A Waters, Kendall T Szeliga et al.

The current study was designed to extend our knowledge of the N-methyl- D-aspartate (NMDA) glutamate receptor system in mediating the discriminative stimulus effects of ethanol in non-human primates. To characterize the discriminative stimulus effects of the NMDA uncompetitive antagonists dizocilpine, phencyclidine (PCP) and ketamine in male and female monkeys under different ethanol training...

Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences

Psychopharmacology April 1, 2002 Suzanne L. Verheyden, J. A. Hadfield, Tara Calin et al. 118 citations

RationaleResearch with animals suggests that central 5-hydroxytryptamine (5-HT) function may be attenuated for a period following a single dose of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). If the same is true in humans, then functions thought to be modulated by 5-HT may differ in MDMA users compared with non-users a few days after the drug is taken.AimsThe present study therefore...

(R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.

Psychopharmacology August 2001 Torbjörn U C Järbe, R J Lamb, S Lin et al.

(R)-methanandamide (AM-356), a metabolically more stable chiral analog of the endocannabinoid ligand anandamide, was used as a representative of fatty acid ethanolamide CB1 receptor ligands to characterize the discriminative stimulus functions of anandamides. Rats discriminated between 10 mg/kg (R)-methanandamide and vehicle administered IP 15 min prior to session onset. Another group of rats...

Psychotogenic properties of benzodiazepine receptor inverse agonists.

Psychopharmacology June 1, 2001 M Sarter, J P Bruno, G G Berntson

The neurochemical, behavioral, and cognitive effects of the benzodiazepine receptor partial inverse agonist beta-carboline FG 7142 (FG), a drug traditionally described as exhibiting 'anxiogenic' effects, are proposed to model core components of present theories of the neuronal mechanisms of schizophrenia. FG activates the mesolimbic dopaminergic system and, via increases in dopaminergic...

Gender differences in the subjective effects of MDMA

Psychopharmacology March 5, 2001 Matthias E. Liechti, Alex Gamma, Franz X. Vollenweider 357 citations

Rationale3.4-Methylenedioxymethamphetamine (MDMA) mainly releases serotonin (5-HT) and is contained in the recreational drug Ecstasy. 5-HT is known to play an important role in mood and anxiety disorders, for which there is a female preponderance. To date, there are no systematic data on gender differences in the subjective effects of MDMA.ObjectivesThe present work analyzed the pooled data...

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

Psychopharmacology February 22, 2001 Jordi Riba, Antoni Rodrı́guez-fornells, Gloria Urbano et al. 302 citations

RationaleAyahuasca is a South American psychoactive beverage that contains the naturally occurring psychedelic agent N,N-dimethyltryptamine (DMT). This "tea" has been used for centuries in religious and medicinal contexts in the rain forest areas of South America and is presently gaining the attention of psychedelic users in North America and Europe.ObjectivesIn the present study, the...

Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine.

Psychopharmacology January 2001 Tanya L. Wallace, Gary A. Gudelsky, Charles V. Vorhees

The long-term neurochemical effects produced by the repeated administration of methamphetamine (MA) and 3,4-methylenedioxymethamphetamine (MDMA) are well documented; however, the functional consequences have not been clearly defined. The present study was designed to investigate whether rats treated with a monoamine-depleting regimen of MA or MDMA exhibit disturbances in locomotor activity...

Cognitive performance and serotonergic function in users of ecstasy.

Psychopharmacology January 1, 2001 R J Verkes, H J Gijsman, M S Pieters et al.

(+/-) 3,4-Methylenedioxymethamphetamine (MDMA or "ecstasy") has been shown to cause long term damage to serotonergic cerebral neurons in animals. The neurotoxic effects in humans are less clear and little is known about the functional consequences, although some studies suggest memory impairment. Given the widespread use of MDMA, our lack of knowledge raises concerns. We investigated, in...

Ecstasy (MDMA): a review of its possible persistent psychological effects

Psychopharmacology September 7, 2000 M. Morgan

Abstract. Rationale: Recreational use of "ecstasy" (3,4-methylenedioxymethamphetamine; MDMA) has become increasingly widespread. Until recently, however, little was known about the possible persistent psychological effects of extensive use of this drug. Objective: The aim of the present review is to evaluate recent empirical evidence concerning the persistent psychological sequelae of...

Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats.

Psychopharmacology August 1, 2000 Karen K. Szumlinski, M Y Balogun, Isabelle M Maisonneuve et al. 28 citations

The phenomenon of sensitization has been theoretically implicated in mediating various aspects of drug addiction. Recent dose-response studies demonstrated that pretreatment with the putative antiaddictive agent, ibogaine (IBO), and a synthetic iboga alkaloid congener, 18-methoxycoronaridine (18-MC), increase the potency of cocaine to elicit behavioral sensitization, an effect proposed to...

DOI: 10.1007/s002130000478 (opens in new tab) Full text (opens in new tab) Stimulant misuse methamphetamine Stimulants Drug self-administration Chronic methamphetamine exposure +11